Table 2:

Association between diagnosis of polymyalgia rheumatica and all first vascular events, by follow-up period

Follow-up periodNo.All vascular events, rate per 1000 person-years (95% CI)Hazard ratio (95% CI)
PMRNo PMRUnadjustedAdjusted*
 6 mo16847.6 (38.8–60.7)14.6 (11.9–17.9)3.3 (2.5–4.5)3.0 (2.2–4.2)
 1 yr32645.5 (38.6–53.7)15.2 (13.2–17.6)3.0 (2.4–3.7)2.7 (2.1–3.4)
 2 yr52241.2 (36.3–46.7)14.7 (13.2–16.4)2.8 (2.4–3.3)2.4 (2.0–2.8)
 5 yr124739.6 (36.3–43.1)14.1 (13.2–15.2)2.8 (2.5–3.1)2.4 (2.1–2.7)
10 yr189237.5 (35.0–40.2)12.9 (12.2–13.8)2.9 (2.6–3.2)2.5 (2.3–2.8)
All follow-up periods217436.1 (33.8–38.5)12.2 (11.6–12.9)2.9 (2.6–3.2)2.6 (2.4–2.9)
  • Note: CI = confidence interval, PMR = polymyalgia rheumatica.

  • * Adjusted for age, sex, ever having smoked, and record of hypertension, hyperlipidemia, diabetes or giant cell arteritis.